Neuraxis (NRXS) Preferred Dividend Payments (2024 - 2025)
Neuraxis' (NRXS) quarterly Preferred Dividend Payments came in at $194882.0 in Q4 2025, up 17.08% year-over-year from $166448.0 in Q4 2024, and down 1.92% quarter-over-quarter from $198707.0 in Q3 2025.
Powered by 
Analysis
Neuraxis (NRXS) Preferred Dividend Payments (2024 - 2025) Analysis & Trends
Neuraxis has disclosed Preferred Dividend Payments across 2 years of filings, most recently posting $194882.0 for Q4 2025.
- In Q4 2025, Preferred Dividend Payments rose 17.08% year-over-year to $194882.0; the TTM figure through Dec 2025 stood at $814597.0 (changed N/A YoY), while the FY2025 annual figure was $814597.0, up 285.58% from the prior year.
- Preferred Dividend Payments came in at $194882.0 for Q4 2025 at Neuraxis, down from $198707.0 in the prior quarter.
- In the past five years, Preferred Dividend Payments ranged from a high of $213543.0 in Q1 2025 to a low of $44820.0 in Q3 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.40 Bn | 175.80 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.21 Bn | 108.39 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.12 Bn | 101.64 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 64.52 Bn | 63.98 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.95 Bn | 45.69 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.09 Bn | 31.63 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.17 Bn | 30.23 Bn | 830.00 Mn | - |
| 9 | Steris | 20.75 Bn | 20.27 Bn | 684.20 Mn | - |
| 10 | Neuraxis | 69.33 Mn | 61.00 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 194,882.00 |
| Sep 30, 2025 | 198,707.00 |
| Jun 30, 2025 | 207,465.00 |
| Mar 31, 2025 | 213,543.00 |
| Dec 31, 2024 | 166,448.00 |
| Sep 30, 2024 | 44,820.00 |